Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03314129 · ClinicalTrials.gov registry record · NA
Remediation of Visual Perceptual Impairments in People With Schizophrenia
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT03314129 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 79 participants.
The verdict
NCT03314129, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of a visual remediation intervention for people with schizophrenia. The intervention targets two visual functions that much research has shown are impaired in many people with the disorder, namely contrast sensitivity and perceptual organization. The first phase of the study will test the effects of interventions targeting each of these processes, as well as the effects of a combined package. A control condition of higher-level cognitive remediation is included as a fourth condition. The second phase of the study will evaluate the effectiveness of the most effective intervention from the first phase, but in a new and larger sample of individuals. Outcome measures include multiple aspects of visual functioning, as well as visual cognition and overall community functioning.
Interventions
- BEHAVIORAL UltimEyes
- BEHAVIORAL Contour Integration Training
- BEHAVIORAL UltimEyes + Contour Integration Training
- BEHAVIORAL MyBrainSolutions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03314129
The ClinicalTrials.gov registry entry for NCT03314129 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which UltimEyes is the first listed.
NCT03314129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03314129 about?
NCT03314129 is a clinical study titled "Remediation of Visual Perceptual Impairments in People With Schizophrenia". The purpose of this study is to evaluate the effectiveness of a visual remediation intervention for people with schizophrenia. The intervention targets two visual functions that much research has shown are impaired in many people with the disorder, namely contrast sensitivity and perceptual organiza...
What is the current status of trial NCT03314129?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2018-06-01. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT03314129?
The interventions under investigation include: UltimEyes (BEHAVIORAL), Contour Integration Training (BEHAVIORAL), UltimEyes + Contour Integration Training (BEHAVIORAL), MyBrainSolutions (BEHAVIORAL).
Who is sponsoring clinical trial NCT03314129?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.